These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8428923)

  • 1. Initial interaction between fibrin and tissue plasminogen activator (t-PA). The Gly-Pro-Arg-Pro binding site on fibrin(ogen) is important for t-PA activity.
    Kaczmarek E; Lee MH; McDonagh J
    J Biol Chem; 1993 Feb; 268(4):2474-9. PubMed ID: 8428923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gly-Pro-Arg-Pro modifies the glutamine residues in the alpha- and gamma-chains of fibrinogen: inhibition of transglutaminase cross-linking.
    Achyuthan KE; Dobson JV; Greenberg CS
    Biochim Biophys Acta; 1986 Aug; 872(3):261-8. PubMed ID: 2873839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Domain-domain interactions in hybrids of tissue-type plasminogen activator and urokinase-type plasminogen activator.
    Bakker AH; Nieuwenbroek NM; Verheijen JH
    Protein Eng; 1995 Dec; 8(12):1295-1302. PubMed ID: 8869642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aggregated, conformationally changed fibrinogen exposes the stimulating sites for t-PA-catalysed plasminogen activation.
    Haddeland U; Sletten K; Bennick A; Nieuwenhuizen W; Brosstad F
    Thromb Haemost; 1996 Feb; 75(2):326-31. PubMed ID: 8815585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the interactions of plasminogen and tissue and vampire bat plasminogen activators with fibrinogen, fibrin, and the complex of D-dimer noncovalently linked to fragment E.
    Stewart RJ; Fredenburgh JC; Weitz JI
    J Biol Chem; 1998 Jul; 273(29):18292-9. PubMed ID: 9660794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrin-mediated plasminogen activation.
    Nieuwenhuizen W
    Ann N Y Acad Sci; 2001; 936():237-46. PubMed ID: 11460481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble fibrin degradation products potentiate tissue plasminogen activator-induced fibrinogen proteolysis.
    Weitz JI; Leslie B; Ginsberg J
    J Clin Invest; 1991 Mar; 87(3):1082-90. PubMed ID: 1900308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical and functional characterization of human tissue-type plasminogen activator variants with mutagenized kringle domains.
    Collen D; Lijnen HR; Bulens F; Vandamme AM; Tulinsky A; Nelles L
    J Biol Chem; 1990 Jul; 265(21):12184-91. PubMed ID: 2115513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The position of the structurally autonomous kringle 2 domain influences the functional features of tissue-type plasminogen activator.
    Bakker AH; Rehberg EF; Marotti KR; Verheijen JH
    Protein Eng; 1995 Mar; 8(3):293-300. PubMed ID: 7479691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the factors contributing to fibrin-dependent plasminogen activation.
    Mosesson MW; Siebenlist KR; Voskuilen M; Nieuwenhuizen W
    Thromb Haemost; 1998 Apr; 79(4):796-801. PubMed ID: 9569195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Introduction of lysine and clot binding properties in the kringle one domain of tissue-type plasminogen activator.
    Bakker AH; van der Greef W; Rehberg EF; Marotti KR; Verheijen JH
    J Biol Chem; 1993 Sep; 268(25):18496-501. PubMed ID: 8395505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sites in fibrin involved in the acceleration of plasminogen activation by t-PA. Possible role of fibrin polymerisation.
    Nieuwenhuizen W
    Thromb Res; 1994 Aug; 75(3):343-7. PubMed ID: 7992246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of tissue-type plasminogen activator binding sites on fibrin using distinct fragments of fibrinogen.
    Grailhe P; Nieuwenhuizen W; Anglés-Cano E
    Eur J Biochem; 1994 Feb; 219(3):961-7. PubMed ID: 8112348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycated proteins modulate tissue-plasminogen activator-catalyzed plasminogen activation.
    Bobbink IW; Tekelenburg WL; Sixma JJ; de Boer HC; Banga JD; de Groot PG
    Biochem Biophys Res Commun; 1997 Nov; 240(3):595-601. PubMed ID: 9398610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The sequence A alpha-(154-159) of fibrinogen is capable of accelerating the t-PA catalysed activation of plasminogen.
    Schielen WJ; Adams HP; Voskuilen M; Tesser GI; Nieuwenhuizen W
    Blood Coagul Fibrinolysis; 1991 Jun; 2(3):465-70. PubMed ID: 1932532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A region of tissue plasminogen activator that affects plasminogen activation differentially with various fibrin(ogen)-related stimulators.
    Eastman D; Wurm FM; van Reis R; Higgins DL
    Biochemistry; 1992 Jan; 31(2):419-22. PubMed ID: 1731899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural features mediating fibrin selectivity of vampire bat plasminogen activators.
    Bringmann P; Gruber D; Liese A; Toschi L; Krätzchmar J; Schleuning WD; Donner P
    J Biol Chem; 1995 Oct; 270(43):25596-603. PubMed ID: 7592732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.
    Wagner OF; de Vries C; Hohmann C; Veerman H; Pannekoek H
    J Clin Invest; 1989 Aug; 84(2):647-55. PubMed ID: 2503541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of residues in the fibrin(ogen) gamma chain involved in tissue plasminogen activator binding and plasminogen activation.
    Wilhelm SE; Lounes KC; Lord ST
    Blood Coagul Fibrinolysis; 2004 Sep; 15(6):451-61. PubMed ID: 15311153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and characterization of novel lysine-independent apolipoprotein(a)-binding sites in fibrin(ogen) alphaC-domains.
    Tsurupa G; Ho-Tin-Noé B; Anglés-Cano E; Medved L
    J Biol Chem; 2003 Sep; 278(39):37154-9. PubMed ID: 12853452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.